9-Aminoellipticine is a synthetic ellipticine derivative that exhibits potent antitumor activity. It is an intercalating agent that binds to DNA, inhibiting DNA replication and transcription. The compound's synthesis involves several steps starting from ellipticine, a natural product isolated from the plant *Ochrosia grandiflora*. 9-aminoellipticine has shown promising preclinical results against various types of cancer, including leukemia, lung cancer, and breast cancer. It is studied because of its unique mechanism of action and its potential as a novel anticancer drug. However, its clinical development has been limited due to toxicity concerns.'
9-aminoellipticine: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 99172 |
SCHEMBL ID | 3342543 |
MeSH ID | M0115579 |
Synonym |
---|
nsc 191345 |
icig 1089 |
6h-pyrido(4,3-b)carbazol-9-amine, 5,11-dimethyl- |
brn 0754366 |
5,11-dimethyl-6h-pyrido(4,3-b)carbazol-9-amine |
ccris 6481 |
6h-pyrido[4,3-b]carbazol-9-amine, 5,11-dimethyl- |
nsc191345 |
nsc-191345 |
9-aminoellipticine |
54779-53-2 |
5,11-dimethyl-6h-pyrido[4,3-b]carbazol-9-amine |
SCHEMBL3342543 |
DTXSID30970101 |
aminoellipticine, 9- |
626V38C3NM |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 8 (53.33) | 18.7374 |
1990's | 7 (46.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.65) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 15 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |